Inventor
VENKATRAMAN SRIKANTH
US40 patents
⚠️ This page may combine multiple inventors who share the name “VENKATRAMAN SRIKANTH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
22 patentsUS6911428B2Jun 28, 2005
Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP124 citations98
US7205330B2Apr 17, 2007
Inhibitors of hepatitis C virus NS3 protease
SCHERING CORP54 citations95
US6914122B2Jul 5, 2005
Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties
SCHERING CORP89 citations95
US6846802B2Jan 25, 2005
Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties
SCHERING CORP124 citations95
US7592316B2Sep 22, 2009
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP34 citations93
US7442695B2Oct 28, 2008
Depeptidized inhibitors of hepatitis C virus NS3 protease
SCHERING CORP22 citations93
US7253160B2Aug 7, 2007
Depeptidized inhibitors of hepatitis C virus NS3 protease
SCHERING CORP39 citations93
US7485625B2Feb 3, 2009
Inhibitors of hepatitis C virus NS3/NS4a serine protease
SCHERING CORP33 citations92
US7342041B2Mar 11, 2008
3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP28 citations92
US7192957B2Mar 20, 2007
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP28 citations92
US7186747B2Mar 6, 2007
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP47 citations92
US7173057B2Feb 6, 2007
Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus
SCHERING CORP44 citations92
US6894072B2May 17, 2005
Compounds as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP59 citations92
US7425576B2Sep 16, 2008
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP20 citations91
US7816326B2Oct 19, 2010
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP9 citations84
US7592419B2Sep 22, 2009
Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
SCHERING CORP11 citations84
US7449447B2Nov 11, 2008
Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP20 citations83
US7423058B2Sep 9, 2008
Inhibitors of hepatitis C virus NS3 protease
SCHERING CORP15 citations83
US7619094B2Nov 17, 2009
Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
SCHERING CORP5 citations62
US7718691B2May 18, 2010
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP0 citations51
US7595299B2Sep 29, 2009
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP0 citations51
US7759499B2Jul 20, 2010
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP0 citations49
ANILKUMAR GOPINADHAN N
4 patentsUS8404845B2Mar 26, 2013
2,3-substituted azaindole derivatives for treating viral infections
ANILKUMAR GOPINADHAN N8 citations83
US8546420B2Oct 1, 2013
4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
ANILKUMAR GOPINADHAN N8 citations82
US8143305B2Mar 27, 2012
2,3-substituted indole derivatives for treating viral infections
ANILKUMAR GOPINADHAN N2 citations48
US8614229B2Dec 24, 2013
Substituted indole derivatives and methods of use thereof
ANILKUMAR GOPINADHAN N0 citations40
MERCK SHARP & DOHME
4 patentsUS9328138B2May 3, 2016
HCV NS3 protease inhibitors
MERCK SHARP & DOHME8 citations80
US8987195B2Mar 24, 2015
HCV NS3 protease inhibitors
MERCK SHARP & DOHME9 citations80
US11161819B2Nov 2, 2021
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists
MERCK SHARP & DOHME0 citations50
US9708270B2Jul 18, 2017
Substituted spiropiperidinyl compounds useful as GPR120 agonists
MERCK SHARP & DOHME0 citations35